Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOF/LDV for HCV infection in thalassemia major (pilot multicenter open-label study)
2015-002401-10Phase 2Completed
- Sponsor
- Casa Sollievo della Sofferenza
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ledipasvir in hepatitis C virus infection and beta thalassemia major, sponsored by Casa Sollievo della Sofferenza. Primary endpoint: SVR12. Started Sep 2021; status: completed.
02
Drugs
ledipasvir
03
Conditions
hepatitis C virus infectionbeta thalassemia major
Beyond the preview
Go deeper on 2015-002401-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002401-10.